Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Roby Zomer and Brett Mitchell are also connected to Graftpolymer - which also operates in Slovenia ....I am not sure if it is at the same place as the MXC operation
https://graftpolymer.com/management/
yes..they both have the same address....
MGC Pharma European Operational Headquarters - Emonska Cesta 8,1000 Ljubljana Slovenia
https://mgcpharma.com.au/contact-us/
GRAFT POLYMER SLOVENIA
Address (office): Emonska cesta 8, 1000 Ljubljana, Slovenia
https://graftpolymer.com/contact-us-2/
Mike_Hunt
What do you know about Graftpolymer and MXC that Roby and Brett are both involved in working out of the same address in Slovenia ?
It's normal Mike. Are you not invested in any UK small cap pharmaceutical companies?
Mike capital rises are needed to take company's forward. Shouldn't be concerned about the past.
Roby Zomer and Brett Mitchell are also connected to Graftpolymer - which also operates in Slovenia ....I am not sure if it is at the same place as the MXC operation
https://graftpolymer.com/management/
Mike Hunt. Appt Nick name!
Mike_Hunt tells you what you should already know !
The loan agreements are in the annual reports...Mercer Street are a US financing company...they will be converting loans to shares in September and November..
There are also 85 million Options due in August @0.145 cent exercisable price ! ..these are tradable on the Australian stock market
Service Agreement with Sibella Capital Pty Ltd, an entity controlled by Mr Mitchell, valid from 1 July 2020 to current
°Fees reduced to $12,000 per month
Services Agreement with Chitta Lu Limited, an entity controlled by Mr Zomer, valid from 1 July 2020 to current•
°Fees reduced to $12,500 per month
They also pay themselves a monthly fee of £900 from MGC Pharma (UK) Limited a subsidiary
It is all there ..you just have to READ it ..nothing is being kept secret ..it is all published in the Annual Report
It might be worth reminding investors (top level) that this play is not about the share price today. It is not about marketing hype and making a quick buck. What it is about is a relatively new player going through the long process of clinical trials and eventually to license. Yes it takes a long time and it will burn cash on the way and so as an investor you will need patience and there will be many ups and downs (that's why it is circa 4 pence a share and not £40) - but when you get through that process the rewards are massive as treatments per patient run into the £thousands/year. When health services/individuals are paying these high prices they want to know what there are buying is going to be effective, non harmful and quality. Once you are in, you are in.
For those who want to gauge performance through the SP, moving further along the clinical trials path will often have the SP digits whirling. I have just bought some more and will have a peek in a few months time.
End of the line for me, way too high risk, I'll take the L.
GLA everyone and hope it works out for ya.
Just ahd a look at hot copper, definitely a
diiferent opinion over there!
Mandello
Completely agree with you there. Links would be appreciated Mike.
I think in Mike_Hunts defence he has made some very serious claims which I am sure can be verified or debunked. Happy to see any links from either side. Im on the fence regards the company atm and actually sold half my shares this am for a 35% loss because of the Aus influence and a nagging feeling in my head that i might be exposed. Emotional attachments and Stocks dont generally end well. Not like the usual deramping with no substance and @Mike_Hunt great name but would you care to share any links to your claims please.
Mike isn't wrong, there's a very different tone on the aussie side of things; lots of talk of unaccounted financing etc.
@mike_hunt; honest question - do you hold a position in this company ?
Easiest way to stop derampers is by calling them out on their arguments or "facts". Just calling them derampers doesn't help anyone.
Or Mr Hunt genuinely is trying to help others! Be it a bit late!
Mike_h just wants to buy your shares cheap otherwise he wouldn’t be here. Beware of derampers, they usually have an ulterior motive!
This same guy is on reddit talking it down, and admitted he is also on twitter talking it down, hes also on HC talking it down and now he's here talking it down. Question why would someone do that.
His username doesn’t inspire confidence though!
I think Mike_Hunt is being unfairly shot down here. He has certainly inspired some further digging and bought to light some things about the company that I (or I think any of us) hadn't realised.
That said, I'm in at 6p avg and I'm just going to hold and see how this one plays out.
I think for the company to succeed it`s
going to have to ditch the aussie listing,
no point in us buying, and then the aussies sell!
Best time to buy is at the idea stage.
The big money comes at the time of execution. The bigger the risk, the higher the potential reward.
DYOR and GLA
Poker,
I'm keen to know then from Junior if he thinks the first building is still on target for June!!??
Mike_Hunt is right...Slovenia no longer have a licence for cannabis growing.....and the new building for growing cannabis on the roof isn't due until 2024
There is still a long way to go with regards all the clinical trials ..they wont get any phase III results of a couple of years
It is all detailed in the prospectus to read
Ok cheers Poker.
The Malta "factory2 is only 480 sq metres
There main building isnt due to open until mid 2024 and it is THAT building that they are looking to grow cannabis on the roof
The 480 sq metre small first building in due to be ready by June ...for the food supplement production and for research
You can see all the plans..they are readily available